Financhill
Back

Intellia Therapeutics Vs. Builders FirstSource Industry Stock Comparison

Sell
21

NTLA
Intellia Therapeutics

Last Price:
21.38
Seasonality Move:
20.01%
Sell
44

BLDR
Builders FirstSource

Last Price:
160.85
Seasonality Move:
2.94%
Sell
21
Intellia Therapeutics (NTLA) is a Sell

Is Intellia Therapeutics a Buy, Sell or Hold?

  • The current Intellia Therapeutics [NTLA] share price is $21.38. The Score for NTLA is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Builders FirstSource (BLDR) is a Sell

Is Builders FirstSource a Buy, Sell or Hold?

  • The current Builders FirstSource [BLDR] share price is $160.79. The Score for BLDR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • BLDR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NTLA Stock Price Chart

What is Intellia Therapeutics's stock price today?

  • The Intellia Therapeutics share price today is $21.38
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing selling pressure, which indicates risk of future bearish movement.

BLDR Stock Price Chart

What is Builders FirstSource's stock price today?

  • The Builders FirstSource share price today is $160.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLDR is experiencing buying pressure, which is a positive indicator for future bullish movement.

NTLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.4 Sell
Relative Strength Index (14 RSI): 34.64 Sell
Chaikin Money Flow: -1632861 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.19 - 25.67) Sell
Bollinger Bands (100): (23.14 - 28.68) Sell

BLDR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.21 Sell
Relative Strength Index (14 RSI): 39.68 Sell
Chaikin Money Flow: 2134853 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (160.77 - 184.17) Sell
Bollinger Bands (100): (169.65 - 198.37) Sell

NTLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.66 Sell
20-day SMA: 24.42 Sell
50-day SMA: 24.14 Sell
200-day SMA: 28.53 Sell
8-day EMA: 23.12 Sell
20-day EMA: 23.84 Sell
50-day EMA: 24.54 Sell
200-day EMA: 29.23 Sell

BLDR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 163.87 Sell
20-day SMA: 169.03 Sell
50-day SMA: 183.77 Sell
200-day SMA: 159.18 Buy
8-day EMA: 163.17 Sell
20-day EMA: 168.84 Sell
50-day EMA: 177.15 Sell
200-day EMA: 161.93 Sell

Intellia Therapeutics Earnings Growth & NTLA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.26 per share, and a decrease next year of $0.37 per share.

Builders FirstSource Earnings Growth & BLDR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.48 per share, a decrease this year of $0.93 per share, and an increase next year of $1.31 per share.

Intellia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Builders FirstSource Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):